Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saeed Bohlega

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Neurology and Therapy|January 4, 2025
Administration and Monitoring Burden of High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis: A Delphi Consensus of Clinical Experts from Saudi ArabiaSeraj Makkawi, Ahmad Abulaban, Yaser Al Malik, et al.
BMC Medical Genetics|July 6, 2019
Truncating ARL6IP1 variant as the genetic cause of fatal complicated hereditary spastic paraplegiaSalma M Wakil, Safa Alhissi, Haya Al Dossari, et al.
The International Journal of Neuroscience|February 19, 2011
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle EastDirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, et al.
Parkinsonism & Related Disorders|February 22, 2023
Expanding the genotype-phenotype landscape of PDE10A-associated movement disordersSaeed Bohlega, Ali H Abusrair, Zainah Al-Qahtani, et al.
Gene|December 10, 2013
Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C>TSalma M Wakil, Khushnooda Ramzan, Rula Abuthuraya, et al.
Human Mutation|November 9, 2011
A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxiaNada Al Tassan, Dania Khalil, Jameela Shinwari, et al.
Journal of Neurology|December 25, 2013
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendationsSeema Kalra, Alan Silman, Gulsen Akman-Demir, et al.
Neuromuscular Disorders : NMD|January 28, 2014
Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndromeDorota M Monies, Hindi N Al-Hindi, Mohamed A Al-Muhaizea, et al.
The International Journal of Neuroscience|April 9, 2010
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory GroupBassem I Yamout, Maurice Dahdaleh, Mohammed Ali Al Jumah, et al.
Multiple Sclerosis International|February 25, 2021
Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert ConsensusMohammed Al Jumah, Yaser Al Malik, Nuha M AlKhawajah, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Neurology and Therapy|January 4, 2025
Administration and Monitoring Burden of High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis: A Delphi Consensus of Clinical Experts from Saudi ArabiaSeraj Makkawi, Ahmad Abulaban, Yaser Al Malik, et al.
BMC Medical Genetics|July 6, 2019
Truncating ARL6IP1 variant as the genetic cause of fatal complicated hereditary spastic paraplegiaSalma M Wakil, Safa Alhissi, Haya Al Dossari, et al.
The International Journal of Neuroscience|February 19, 2011
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle EastDirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, et al.
Parkinsonism & Related Disorders|February 22, 2023
Expanding the genotype-phenotype landscape of PDE10A-associated movement disordersSaeed Bohlega, Ali H Abusrair, Zainah Al-Qahtani, et al.
Gene|December 10, 2013
Infantile-onset ascending hereditary spastic paraplegia with bulbar involvement due to the novel ALS2 mutation c.2761C>TSalma M Wakil, Khushnooda Ramzan, Rula Abuthuraya, et al.
Human Mutation|November 9, 2011
A missense mutation in PIK3R5 gene in a family with ataxia and oculomotor apraxiaNada Al Tassan, Dania Khalil, Jameela Shinwari, et al.
Journal of Neurology|December 25, 2013
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendationsSeema Kalra, Alan Silman, Gulsen Akman-Demir, et al.
Neuromuscular Disorders : NMD|January 28, 2014
Clinical and pathological heterogeneity of a congenital disorder of glycosylation manifesting as a myasthenic/myopathic syndromeDorota M Monies, Hindi N Al-Hindi, Mohamed A Al-Muhaizea, et al.
The International Journal of Neuroscience|April 9, 2010
Adherence to disease-modifying drugs in patients with multiple sclerosis: a consensus statement from the Middle East MS Advisory GroupBassem I Yamout, Maurice Dahdaleh, Mohammed Ali Al Jumah, et al.
Multiple Sclerosis International|February 25, 2021
Family Planning for People with Multiple Sclerosis in Saudi Arabia: an Expert ConsensusMohammed Al Jumah, Yaser Al Malik, Nuha M AlKhawajah, et al.
Pageof 7